https://www.selleckchem.com/pr....oducts/n-butyl-n-4-h
001). Subjects with CD-EoE were less likely to have perianal disease than CD alone (2% vs 20%, P = 0.004). There was no difference in fibrostenotic EoE between the dual-diagnosis group and EoE alone. Treatment with a TNF-alpha inhibitor (anti-TNF) for management of preexisting IBD was protective against development of EoE with a relative risk of 0.314 [95% confidence interval [CI] 0.159-0.619]. This is a unique population in whom the underlying pathway leading to dual-diagnosis is unclear. Concomitant atopic
Beğen
Yorum Yap
Paylaş
